This page shows the latest Coronavirus vaccine news and features for those working in and with pharma, biotech and healthcare.
Merck &Co (MSD) has ended its COVID-19 vaccine programme after reviewing some disappointing phase 1 results for its candidates V590 and V591. ... We are grateful to our collaborators who worked with us on these vaccine candidates and to the volunteers in
Moderna has announced that its COVID-19 vaccine appears effective against new coronavirus variants discovered in the UK and South Africa (SA). ... BioNTech is also planning to publish an additional analysis of the vaccine's efficacy against the
Up to 40 million doses will be supplied to the international vaccine-sharing facility. ... Pfizer and BioNTech have agreed to supply up to 40 million doses of their COVID-19 vaccine to COVAX, the international vaccines-sharing facility.
New results from a laboratory study of Pfizer/BioNTech’s COVID-19 vaccine have found that the vaccine should protect immunised individuals against the new coronavirus strain first identified in the ... BioNTech is also planning to publish an additional
The European Union is proposing the creation of a vaccine-sharing mechanism in order to deliver COVID-19 jabs to priority groups in low-income countries, according to the EU’s ... This week, WHO director-general Tedros Adhanom Ghebreyesus said that
US pharma Johnson &Johnson (J&J) is planning to launch its single-dose COVID-19 vaccine in March, according to the company’s chief scientific officer Paul Stoffels. . ... J&J previously signed an advance purchase agreement with the European Commission
More from news
Approximately 30 fully matching, plus 46 partially matching documents found.
Coronavirus will be a blip on the horizon in comparison. The risk is trivial.”. ... Notably, Russia’s Sputnik V vaccine, developed by Moscow’s Gamaleya research centre, and announced by President Vladimir Putin in August as being the world’s
The conference listings for 2020 were well established, but as the coronavirus became a more severe threat, the months of upfront planning were put on hold. ... In April this year there were 650 groups around the world carrying out 460 different
GlaxoSmithKline has also partnered with Chinese biotech company Clover Biopharmaceuticals on a protein-based coronavirus vaccine candidate, named COVID-19 S-Trimer. ... Translate has already begun to produce multiple mRNA constructs and will use its
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... The Thalidomide Society has said that comparisons between thalidomide and the COVID-19 vaccine are “insulting”.
Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine.
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it. ... Essentially, people with diabetes will remain at extreme risk, until a coronavirus vaccine becomes available and
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we provide custom solutions and strategic recommendations that go beyond research, helping our
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....